Islet Cell Tumor

17 registered clinical trials studyying Islet Cell Tumor — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors NCT02038738	Ochsner Health System	Phase 1 / Phase 2
Terminated	Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET NCT01374451	Novartis Pharmaceuticals	Phase 2
Terminated	Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors NCT00730483	Yale University	N/A
Completed	AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors NCT00427349	Eastern Cooperative Oncology Group	Phase 2
Completed	Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization NCT00434109	H. Lee Moffitt Cancer Center and Research Institute	Phase 2
Unknown	Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroend NCT00454376	National Cancer Institute (NCI)	—
Completed	Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic N NCT00602082	Cambridge University Hospitals NHS Foundation Trust	Phase 2
Terminated	Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors NCT00227617	University of California, San Francisco	Phase 2 / Phase 3
Completed	Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroe NCT00416767	Federation Francophone de Cancerologie Digestive	Phase 2
Terminated	Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors NCT00466856	Vanderbilt-Ingram Cancer Center	Phase 2
Completed	Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors NCT00049023	O'Dorisio, M S	Phase 1
Completed	PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors NCT00017199	Ohio State University Comprehensive Cancer Center	Phase 2
Completed	Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors NCT00027638	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Dis NCT00830557	Mayo Clinic	—
Completed	Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver NCT00019786	National Institutes of Health Clinical Center (CC)	Phase 2
Completed	Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer NCT00006368	Novartis Pharmaceuticals	Phase 1
Terminated	Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer NCT00002947	Yale University	Phase 1